Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1990. Start Trial.
Date Value
October 28, 2026 185.87
October 27, 2026 194.26
October 26, 2026 194.87
October 23, 2026 193.53
October 22, 2026 195.29
October 21, 2026 190.75
October 20, 2026 193.07
October 19, 2026 188.61
October 16, 2026 188.80
October 15, 2026 186.94
October 14, 2026 182.55
October 13, 2026 176.45
October 12, 2026 178.93
October 09, 2026 177.33
October 08, 2026 177.48
October 07, 2026 179.31
October 06, 2026 177.71
October 05, 2026 177.52
October 02, 2026 179.35
October 01, 2026 179.92
September 30, 2026 183.69
September 29, 2026 188.19
September 28, 2026 189.53
September 25, 2026 187.77
September 24, 2026 189.34
Date Value
September 23, 2026 189.57
September 22, 2026 193.42
September 21, 2026 194.79
September 18, 2026 191.51
September 17, 2026 194.71
September 16, 2026 191.78
September 15, 2026 190.71
September 14, 2026 190.86
September 11, 2026 183.54
September 10, 2026 183.50
September 09, 2026 185.45
September 08, 2026 185.10
September 04, 2026 190.25
September 03, 2026 193.99
September 02, 2026 192.35
September 01, 2026 193.19
August 31, 2026 191.63
August 28, 2026 193.80
August 27, 2026 191.70
August 26, 2026 196.13
August 25, 2026 198.57
August 24, 2026 197.46
August 21, 2026 199.86
August 20, 2026 198.15
August 19, 2026 201.65

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
AstraZeneca PLC 427.87
Johnson & Johnson 646.76
Eli Lilly & Co. 3403.96
Merck & Co., Inc. 435.81
Novo Nordisk A/S 68.52